662 J. Am. Chem. Soc., Vol. 120, No. 4, 1998
Burk et al.
(
2Z,4E)-Methyl 2-Acetamido-5,9-dimethyldeca-2,4,8-trienoate (1e).
(2R,4E)-Methyl 2-Acetamido-6-((tert-butyldimethylsilyl)oxy)hex-
4-eneoate (2d). General Procedure. Methyl 2-acetamido-6-((tert-
butyldimethylsilyl)oxy)hexa-2,4-dienoate (1d) (1.7 g, 5.4 mmol) and
[(COD)Rh(R,R)-Et-DuPHOS]OTf (7.0 mg) were dissolved in MeOH
Obtained as a white solid by method B (3.1 g, 77%): R 0.35 (1:1
system A); mp 91.2-92.2 °C (needles from PE:EA); H NMR δ 1.56,
.64, 1.87 (3s, 3H ea.), 2.10-2.20 (m, 4H), 2.12 (s, 3H), 3.75 (s, 3H),
.04 (br s, 1H), 5.93 (d, 1H, J ) 14.9 Hz), 6.89 (br s, 1H), 7.34 (d,
H, J ) 11.8 Hz, H-3); C NMR δ 14.1, 17.7, 23.5, 25.6, 26.4, 40.7,
2.3, 120.1, 123.4, 130.2, 132.5, 133.0, 150.6, 167.0, 168.6; HRMS
calcd for C15
(
f
1
1
5
1
5
2
(125 mL), and the vessel was charged with H (90 psi). After 2 h the
1
3
H
2
was vented and the solvent was evaporated. The crude material
was passed through a short plug of silica with acetone before the optical
purity was assayed by GC. Chromatography on silica gave pure 2d
+
H24NO
3
(M + H ) m/z 266.1756, found 266.1745.
2Z)-Methyl 2-Acetamido-4-ethylpenta-2,4-dienoate (1f). Ob-
(1.6 g, 95%): R
f
0.39 (1:2 system A); t
-45.8° (c ) 1.25, CHCl ); H NMR δ 0.02 (s, 6H),
R
7.36 min (160 °C, 30 psi,
>99% ee); [R]20
1
tained as a white solid by method B (0.15 g, 18%): R 0.67 (1:1 system
f
D
3
1
A); mp 72-73 °C (needles from PE:EA); H NMR δ 0.99 (t, 3H, 7.40
Hz), 2.04 (s, 3H), 2.20 (q, 2H, H)7.24 Hz), 3.74 (s, 3H), 5.23 (s, 2H),
.86 (s, 1H), 7.14 (br s, 1H); C NMR δ 12.7, 23.1, 27.5, 52.5, 119.6,
0.86 (s, 9H), 1.98 (s, 3H), 2.40-2.60 (m, 2H), 3.70 (s, 3H), 4.08 (dd,
2H, J ) 1.2, 4.8 Hz), 4.60-4.70 (m, 1H), 5.40-5.60 (m, 2H), 5.60
1
3
13
6
1
(br d, 1H, J ) 7.5 Hz); C NMR δ 18.3, 23.1, 25.9, 34.8, 51.8, 52.3,
24.0, 134.1, 145.0, 165.7, 169.2; HRMS calcd for C10
H16NO
3
(M +
63.2, 123.7, 134.1, 169.6, 172.3; HRMS calcd for C15
H ) m/z 316.1944, found 316.1943.
H30NO
4
Si (M +
+
+
H ) m/z 198.1130, found 198.1140.
(
2Z)-Methyl 2-Acetamido-3-(1-cyclohexeneyl)prop-2-enoate (1 h).
Obtained as a white solid (0.27 g, 17%): R 0.28 (1:2 system A); mp
45.5-146.4 °C (needles from EA:PE); H NMR δ 1.45-1.65 (m,
(2R,4E)-Methyl 2-Acetamido-5,9-dimethyldeca-4,8-dienoate (2e).
f
After 2 h reaction time at 90 psi initial pressure: R 0.42 (1:2 system
f
1
20
1
4
1
2
A); t 8.97 min (180 °C, 30 psi, >99% ee); [R] -63.3° (c ) 1.16,
R
D
1
H), 1.95-2.40 (m, 4H), 2.04 (s, 3H), 3.70 (s, 3H), 6.10-6.15 (m,
H), 6.99 (s, 1H), 7.09 (br s, 1H); C NMR δ 21.3, 22.4, 23.1, 25.9,
6.4, 52.3, 120.2, 134.1, 139.1, 139.7, 166.2, 169.9; HRMS calcd for
CHCl ); H NMR δ 1.56, 1.57 (2s, 6H), 1.65 (s, 3H), 1.90-2.20 (m,
3
1
3
2H), 1.97 (s, 3H), 2.40-2.60 (m, 2H), 3.70 (s, 3H), 4.55-4.70 (m,
1H), 4.90-5.10 (m, 2H), 6.00 (d, 1H, J ) 7.4 Hz); 13C NMR δ 16.0,
17.7, 23.1, 25.6, 26.4, 30.5, 39.7, 52.0, 52.2, 117.3, 123.8, 131.6, 134.0,
+
C
12
H
17NO
3
(M + H ) m/z 224.1287, found 224.1283.
+
(
2Z,4E)-Methyl 2-Acetamidohexa-2,4-dienoate (1i). Separated a
mixture of 4E and 4Z (97:3 4E:4Z, 2.0 g, 70%). 4E was obtained as
a white solid by method B: R
169.5, 172.6; HRMS calcd for C H NO (M + H ) m/z 268.1913,
1
5
26
3
found 268.1907.
f
0.33 (1:2 system A); mp 89.0-90.1 °C
needles from PE:EA); H NMR δ 1.75 (d, 3H, J ) 5.6 Hz), 2.02 (s,
(2R)-Methyl 2-Acetamido-4-ethylpenta-4-enoate (2f). After 2 h
1
(
reaction time at 60 psi initial pressure: R
f
0.27 (1:1 system A); t
R
5.70
); H
3
(
H), 3.69 (s, 3H), 5.95-6.30 (m, 2H), 6.92 (d, 1H, J ) 10.1 Hz), 7.59
br s, 1H); C NMR δ 18.8, 23.0, 52.1, 121.3, 126.5, 134.2, 139.2,
20
1
min (120 °C, 20 psi, 97.8% ee); [R]
D
-23.6° (c ) 1.28, CHCl
3
1
3
NMR δ 1.00 (t, 3H, J ) 7.4 Hz), 1.90-2.10 (m, 2H), 1.98 (s, 3H),
.37 (dd, 1H, J ) 8.2 Hz, J ) 14.0 Hz), 2.54 (dd, 1H, J ) 5.6 Hz, J
14.0 Hz), 3.70 (s, 3H), 4.60-4.70 (m, 1H), 4.74 (s, 1H), 4.83 (s,
+
1
65.4, 169.1; HRMS calcd for C
found 184.0978.
2Z,4E)-Methyl 2-Acetamido-5-tert-butylpenta-2,4-dienoate (1j).
Obtained as a white solid by method A (0.73 g, 72%): R 0.29 (1:1
9
H13NO
3
(M + H ) m/z 184.0974,
2
)
1
5
(
(
13
H), 5.89 (d, 1H, J ) 6.0 Hz); C NMR δ 12.1, 23.0, 28.0, 39.0,
0.6, 52.3, 112.1, 146.0, 170.0, 172.9; HRMS calcd for C10 18NO
3
f
H
1
system A); mp 101.6-102.6 °C (needles from PE:EA); H NMR δ
+
M + H ) m/z 200.1287, found 200.1291.
0
6
2
.96 (s, 9H), 2.03 (s, 3H), 3.66 (s, 3H), 6.01 (dd, 1H, J ) 3.9 Hz),
(2S)-Methyl 2-Acetamido-3-cyclohexenylpropanoate (2 h). After
.03 (s, 1H), 6.92 (dd, 1H, J ) 3.3, 3.6 Hz), 7.73 (s, 1H); 13C NMR δ
2
h reaction time at 90 psi initial pressure: R
f
0.29 (1:2 system A); t
R
2.9, 28.8, 33.8, 52.0, 120.0, 121.9, 134.7, 154.8, 165.4, 169.2; HRMS
calcd for C12
20
7
.25 min (150 °C, 20 psi, 99.5% ee); [R]
D
+29.8° (c ) 2.01, CHCl
3
);
+
H19NO
3
(M + H ) m/z 225.1365, found 225.1372.
1
H NMR δ 1.40-1.60 (m, 2H), 1.80-2.00 (m, 2H), 1.95 (s, 3H), 2.20-
(
2Z,4E)-Methyl 2-Acetamido-5-phenylpenta-2,4-dienoate (1l).
Obtained as a white solid by method A (0.31 g, 55%): R 0.35 (9:1
system B); mp 179.4-180.2 °C (needles from EA); H NMR δ 2.02
2
(
5
(
.50 (m, 2H), 3.66 (s, 3H), 4.55-4.70 (m, 1H), 5.41 (br s, 1H), 5.98
f
13
d, 1H, J ) 7.2 Hz); C NMR δ 22.0, 22.6, 22.9, 25.2, 27.7, 40.8,
1
0.6, 52.1, 125.6, 132.7, 169.7, 173.1; HRMS calcd for C12
H20NO
3
(
(
s, 3H), 3.80 (s, 3H), 6.85-6.90 (m, 2H), 7.07 (br s, 1H), 7.20-7.50
m, 6H); C NMR δ 23.7, 52.5, 122.8, 123.7, 127.3, 128.6, 130.0,
+
M + H ) m/z 226.1443, found 226.1435.
1
3
(
2R,4E)-Methyl 2-Acetamidohexa-4-enoate (2i). After 2 h reaction
time at 90 psi initial pressure: R 0.41 (1:2 system A); t 4.18 min
120 °C, 20 psi, 99.3% ee); [R]20
-57.2° (c ) 1.18, CHCl
δ 1.62 (d, 3H, J ) 6.1 Hz), 1.98 (s, 3H), 1.80-2.00 (m, 2H), 3.70 (s,
1
32.7, 136.2, 140.0, 165.4, 168.7; HRMS calcd for C14
H15NO
3
(M +
+
f
R
H ) m/z 254.1052, found 254.1045.
1
(
D
3
); H NMR
Substrate Hydrogenations. (2R,4Z)-Methyl 2-Acetamido-6-((tert-
butyldimethylsilyl)oxy)hex-4-eneoate (2a). After 2 h reaction time
at 60 psi initial pressure: R
3
(
1
1
H), 4.55-4.70 (m, 1H), 5.20-5.40 (m, 1H), 5.45-5.60 (m, 1H), 6.00
f
0.44 (9:1 system B); t
-32.6° (c ) 2.03, CHCl
R
7.36 min (160 °C,
); H NMR δ 0.02
br s, 1H); 13C NMR δ 18.0, 23.1, 35.2, 51.9, 52.3, 124.3, 130.0, 169.6,
2
0
1
3
(
0 psi, 99.3% ee); [R]
D
3
+
72.5; HRMS calcd for C
86.1135.
9
H
16NO
3
(M + H ) m/z 186.1130, found
s, 6H), 0.84 (s, 9H), 1.95 (s, 3H), 2.40-2.60 (m, 2H), 3.68 (s, 3H),
4
1
1
.12 (dd, 2H, J ) 0.7, 6.2 Hz), 4.50-4.70 (m, 1H), 5.20-5.40 (m,
13
(2S,4E)-Methyl 2-Acetamidohexa-4-enoate (ent-2i). After 2 h
reaction time at 90 psi initial pressure: t 4.97 min (120 °C, 20 psi,
99.2% ee); [R]20
+62.0° (c ) 0.99, CHCl ); please see 2i for other
characterization data.
(2S,4E)-Methyl 2-Acetamido-5-tert-butylpent-4-eneoate (2j). Af-
ter 1 h reaction time at 30 psi initial pressure: R 0.55 (1:2 system A);
tR 3.47 min (150 °C, 20 psi, 99.4% ee); [R]20 +61.4° (c ) 1.03,
H), 5.60-5.80 (m, 1H), 6.30 (br d, 1H, J ) 7.1 Hz); C NMR δ
R
8.3, 23.0, 25.8, 29.8, 51.5, 52.3, 59.0, 124.3, 133.3, 169.8, 172.2;
+
D
3
HRMS calcd for C15
H30NO
4
Si (M + H ) m/z 316.1944, found
3
16.1940.
2R,4E)-Methyl 2-Acetamido-6-phenylhex-4-eneoate (2b). After
.5 h reaction time at 30 psi initial pressure: R 0.47 (1:2 system A);
(
0
f
0
f
2
t
R
5.08 min (180 °C, 30 psi, 98.2% ee); [R]
CHCl
D
-61.1° (c ) 1.01,
D
1
CHCl3); H NMR δ 0.98 (s, 9H), 2.02 (s, 3H), 2.38-2.60 (m, 2H),
1
3
); H NMR δ 1.98 (s, 3H), 2.40-2.60 (m, 2H), 3.30-3.40 (m,
2
(
H), 3.70 (s, 3H), 4.60-4.70 (m, 1H), 5.35-5.50 (m, 1H), 5.60-5.75
3.74 (s, 3H), 4.60-4.70 (m, 1H), 5.18 (ddd, 1H, J ) 7.2, 15.6 Hz),
1
3
5.53 (d, 1H, J ) 15.6 Hz), 6.02 (br d, 1H, J ) 7.2 Hz); 13C NMR δ
m, 1H), 7.10-7.35 (m, 6H); C NMR δ 13.6, 19.7, 23.0, 24.0, 35.2,
5
1.8, 52.3, 58.8, 124.8, 126.1, 128.4, 134.0, 140.1, 169.5, 172.4; HRMS
23.1, 29.4, 33.1, 35.5, 52.0, 52.2, 105.6, 117.8, 146.7, 169.5, 172.4;
+
HRMS calcd for C H NO Si (M + H ) m/z 228.1600, found
+
calcd for C15
(
H30NO
4
Si (M + H ) m/z 262.1443, found 262.1438.
12 22
3
2
28.1592.
2S,4E)-Methyl 2-Acetamido-4-methylhex-4-eneoate (2c). After
2
h reaction time at 90 psi initial pressure: R
f
0.33 (1:1 system A); t
R
(2R,4E)-Methyl 2-Acetamido-5-phenylpenta-4-enoate (2l). After
20
4
.28 min (135 °C, 20 psi, 99.5% ee); [R]
D
+24.3° (c ) 1.02, CHCl
3
);
2 h reaction time at 90 psi initial pressure: R
f
0.30 (4:1 system B); t
R
1
20
H NMR δ 1.61 (m, 6H), 2.00 (s, 3H), 2.29 (dd, 1H, J ) 8.1, 16.5
Hz), 2.46 (dd, 1H, J ) 5.7, 13.2 Hz), 3.73 (s, 3H), 4.60 (ddd, 1H, J )
5.04 min (180 °C, 30 psi, 98.6% ee); [R]
D
-90.8° (c ) 1.11, CHCl
3
);
1
H NMR δ 1.93 (s, 3H), 2.50-2.80 (m, 2H), 3.67 (s, 3H), 4.60-4.75
(m, 1H), 5.96 (dt, 1H, J ) 7.4 Hz, J ) 15.7 Hz), 6.16 (br d, 1H, 7.5
7
.8, 13.5 Hz), 5.24 (q, 1H, J ) 6.0 Hz), 5.86 (br d, 1H, J ) 6.0 Hz);
1
3
13
C NMR δ 13.4, 15.2, 22.8, 42.2, 50.7, 52.1, 123.1, 130.5, 167.8, 173.0;
Hz), 6.37 (d, 1H, J ) 15.8 Hz), 7.10-7.30 (m, 5H); C NMR δ 23.1,
+
HRMS calcd for C15
2
H30NO
4
Si (M + H ) m/z 200.1287, found
35.7, 51.9, 52.4, 123.3, 126.1, 127.5, 128.5, 134.0, 136.6, 169.7, 172.3;
+
00.1296.
HRMS calcd for (M + H ) m/z 248.1287, found 248.1282.